Last checked at 7 Jun 2021 15:28
7 June 2021
Eden Research Plc
("Eden" or "Company")
Notice of AGM, virtual investor conference and 2020 Accounts
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces that its Notice of the Annual General Meeting ("AGM") has been issued to shareholders and is now available on the Company's website: www.edenresearch.com
The AGM is to be held on Wednesday 30 June 2021 at 12.00pm at 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ.
In accordance with current Government regulations in relation to COVID-19, shareholders are encouraged to submit their Form of Proxy in advance of the General Meeting and are strongly discouraged from attending the General Meeting in person to safeguard the Company's shareholders' and employees' health, to comply with current Government guidelines, to minimise the unnecessary movement of people and to make the AGM as safe and efficient as possible.
Should shareholders wish to ask any questions in relation to the Resolutions, which they may otherwise have asked at the AGM, had they been in attendance, they are encouraged to contact the Company prior to the AGM by email at agm@edenresearch.com.
Virtual Investor Conference
Given the advised restrictions in place for the AGM due to COVID-19, the Company shall be holding a virtual investor conference at 1pm on 30 June 2021, where the executive team at Eden shall make a presentation to shareholders and other interested parties and shall answer questions that have been submitted to the Board ahead of time. Should you have any questions for the Board, please send them by email to agm@edenresearch.com by 5pm on Friday 25 June 2021.
Details of how to join the virtual investor conference shall follow in due course.
2020 Accounts
In addition, and following discussions with the Company's auditors and regulatory guidance in relation to the ongoing COVID-19 pandemic, the Company has received an extension to the timeline for filing its 2020 Accounts at Companies House. Accordingly, the Company's consolidated accounts for the year ended 31 December 2020 (the "2020 Accounts") will not be presented at the AGM.
The Company continues to work with its auditors to finalise its 2020 Accounts and, when available, the Company will issue an RNS and dispatch the annual report and accounts to shareholders. At that stage the Company intends to call a further general meeting to receive the annual report and accounts.
For further information contact:
Eden Research plc | www.edenresearch.com |
Sean SmithAlex Abrey | 01285 359 555 |
Cenkos Securities plc (Nominated advisor and broker) | |
Giles Balleny / Camilla Hume/ Mark Connelly (corporate finance)Michael Johnson (sales) | 020 7397 8900 |
Hawthorn Advisors (Financial PR) | |
Lorna Cobbett / Victoria Ainsworth | eden@hawthornadvisors.com |
Notes to Editors:
Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.
For more information about Eden, please visit: www.edenresearch.com.